In their studies, Svärd et al. discovered that the levels of RgpB antibodies in RA patients were significantly higher than in healthy controls, although they did not find a correlation between these antibodies and ACPA positivity levels [62]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.